肺気腫治療の世界市場レポート 2024年

肺気腫治療市場規模は近年力強く成長しています。2023年の49億6,000万米ドルから2024年には52億9,000万米ドルへ、CAGR6.5％で拡大します。過去の期間に見られた拡大は、喫煙の蔓延の影響、薬剤の進歩、肺リハビリテーションプログラムの実施、診断ツールの強化、意識と教育の向上に起因しています。

肺気腫治療市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR 6.7％で68億5,000万米ドルに成長します。予測期間中に予想される成長は、高齢化の動向、カスタマイズされた治療アプローチの採用、治療法への幅広いアクセス、症状管理の重視、共同ヘルスケアモデルの導入などに関連しています。予測期間中に予想される主な動向には、遺伝子治療の探求、患者教育とエンパワーメントのための取り組み、人工知能（AI）の統合、治療へのアクセスの改善、長時間作用型薬剤の開発などが含まれます。

慢性閉塞性肺疾患（COPD）の有病率の増加が予想されることから、肺気腫治療市場の成長が見込まれます。COPDは肺気腫や慢性気管支炎を含む疾患群で構成され、気流閉塞や呼吸困難を引き起こします。肺気腫治療は、症状管理、肺機能の回復、病気の進行を遅らせることに重点を置き、COPDの進行を緩和する上で重要な役割を果たしています。2021年9月に国際呼吸器学会フォーラムが発表した調査によると、2021年には約2億人がCOPDと診断され、年間死亡率は約320万人で、世界の死亡原因の第3位であることが明らかになりました。したがって、COPD患者の有病率の増加が肺気腫治療市場の原動力となっています。

大気汚染の急増は、肺気腫治療市場の成長に寄与すると予想されます。大気汚染は、大気中に有害物質が存在することを特徴とし、環境や人間の健康に悪影響を及ぼします。大気汚染に含まれる粒子状物質や有害ガスのレベルが上昇すると、肺気腫などのCOPDを含む呼吸器疾患が悪化する可能性があります。大気汚染物質への曝露の増加は、呼吸器疾患の増加につながり、肺気腫治療の需要を促進する可能性が高いです。例えば、2021年9月、スイスに本拠を置く大気環境技術会社IQAirは、マレーシアのPM2.5濃度が前年比で25％上昇したと報告しました。2021年の年間平均値は19.4μg/m3で、2020年に観測されたレベルから3.8μg/m3の大幅な上昇を記録しました。その結果、大気汚染の急増が肺気腫市場の成長を促進しています。

2023年の肺気腫治療市場では北米が最大地域でした。肺気腫治療市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 市場促進要因・市場抑制要因
  • 市場促進要因
  • 市場抑制要因
• 市場規模と成長実績、2018～2023年
• 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の肺気腫治療市場、治療別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 禁煙
• 気管支拡張薬
• ステロイド
• ロイコトリエン受容体拮抗薬
• 酸素補給
• 抗生物質
• 遺伝子治療
• 移植手術
• その他
• 世界の肺気腫治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• オンラインプロバイダー
• ドラッグストア・小売薬局
• 病院薬局
• 世界の肺気腫治療市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• クリニック
• 外科センター
• その他

第7章 地域および国の分析

• 世界の肺気腫治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の肺気腫治療市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 肺気腫治療市場の競合情勢
• 肺気腫治療市場の企業プロファイル
  • AstraZeneca PLC
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • GlaxoSmithKline PLC
  • Hikma Pharmaceuticals PLC

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

“Emphysema Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on emphysema treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for emphysema treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The emphysema treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Treatment: Smoking Cessation; Bronchodilators; Steroids; Leukotriene Modifiers; Supplemental Oxygen; Antibiotics; Gene Therapy; Surgery Transplant; Other Treatments
• 2) By Distribution Channel: Online Providers; Drug Stores and Retail Pharmacies; Hospital Pharmacies
• 3) By End-User: Clinics; Surgical Centre; Other End-Users
• Companies Mentioned: AstraZeneca PLC; Teva Pharmaceutical Industries Ltd.; Novartis AG; GlaxoSmithKline PLC; Hikma Pharmaceuticals PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Emphysema treatment refers to medication for chronic obstructive pulmonary disease (COPD), a condition that leads to damage in the air sacs of the lungs, resulting in difficulty breathing. Treatments for emphysema aim to manage symptoms and slow the progression of the disease.

The primary treatments for emphysema include smoking cessation, bronchodilators, steroids, leukotriene modifiers, supplemental oxygen, antibiotics, gene therapy, surgery transplant, and others. Smoking cessation involves the cessation of smoking to reduce the risk of cancer and other significant health issues. This process helps minimize cravings and withdrawal symptoms while preventing nicotine binding. These treatments are available through various distribution channels, including online providers, drug stores, retail pharmacies, and hospital pharmacies. They are utilized by various end-users such as clinics, surgical centers, and others.

The emphysema treatment market research report is one of a series of new reports from The Business Research Company that provides emphysema treatment market statistics, including emphysema treatment industry global market size, regional shares, competitors with an emphysema treatment market share, detailed emphysema treatment market segments, market trends and opportunities, and any further data you may need to thrive in the emphysema treatment industry. This emphysema treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The emphysema treatment market size has grown strongly in recent years. It will grow from $4.96 billion in 2023 to $5.29 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The expansion observed in the historical period can be ascribed to the impact of the smoking epidemic, advancements in medications, the implementation of pulmonary rehabilitation programs, enhanced diagnostic tools, and increased awareness and education.

The emphysema treatment market size is expected to see strong growth in the next few years. It will grow to $6.85 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The anticipated growth in the forecast period can be linked to trends in the aging population, the adoption of customized treatment approaches, broader access to therapies, an emphasis on symptom management, and the implementation of collaborative healthcare models. Major trends expected in the forecast period involve the exploration of gene therapies, initiatives for patient education and empowerment, the integration of artificial intelligence (AI), improved accessibility to treatment, and the development of long-acting medications.

The anticipated increase in the prevalence of chronic obstructive pulmonary disease (COPD) cases is poised to drive the growth of the emphysema treatment market. COPD comprises a group of disorders, including emphysema and chronic bronchitis, leading to airflow obstruction and breathing difficulties. Emphysema treatments play a crucial role in mitigating the progression of COPD, focusing on symptom management, restoration of lung function, and delaying disease advancement. A study released by the Forum of International Respiratory Societies in September 2021 revealed that approximately 200 million people were diagnosed with COPD in 2021, with an annual mortality rate of around 3.2 million, ranking it as the third-leading cause of global mortality. Hence, the increasing prevalence of COPD cases is a driving force behind the emphysema treatment market.

The surge in air pollution is expected to contribute to the growth of the emphysema treatment market. Air pollution, characterized by the presence of harmful substances in the air, poses adverse effects on the environment and human health. Elevated levels of particulate matter and harmful gases in air pollution can exacerbate respiratory conditions, including COPD such as emphysema. The heightened exposure to air pollutants is likely to lead to an increase in respiratory diseases, fostering the demand for emphysema treatments. For example, in September 2021, IQAir, a Switzerland-based air quality technology company, reported a 25% rise in PM2.5 concentrations in Malaysia compared to the previous year. The recorded annual average for 2021, at 19.4 μg/m3, marked a significant increase of 3.8 μg/m3 from the levels observed in 2020. Consequently, the upsurge in air pollution is propelling the growth of the emphysema market.

Prominent companies in the emphysema market are striving to gain a competitive advantage by developing minimally invasive procedures tailored for emphysema patients. Minimally invasive procedures involve medical interventions or surgical techniques that aim to cause minimal disruption to the body's normal structures. For example, in January 2022, Adena Health System, a healthcare company based in the United States, introduced Zephyr Valve surgery as a minimally invasive alternative to traditional lung volume reduction surgery for individuals experiencing lung hyperinflation, a common issue in emphysema and COPD. This innovative procedure involves the placement of small, one-way Zephyr Valves in the lungs' airways through a bronchoscope. These valves facilitate the release of trapped air, preventing further accumulation and enabling healthier lung areas to expand, thereby improving breathing.

Leading companies in the emphysema market are also focusing on the development of innovative products, such as inhalation aerosols, to establish a competitive edge. Inhalation aerosols are pharmaceutical formulations dispensed as a fine mist or spray of liquid medication suspended in a propellant or propellant mixture. For instance, in July 2023, Viatris Inc., a U.S.-based pharmaceutical company, in collaboration with Kindeva Drug Delivery L.P., a U.S.-based pharmaceutical contract development and manufacturing organization (CDMO), launched Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol. This marks the first FDA-approved generic version of AstraZeneca's Symbicort, catering to patients managing asthma, chronic obstructive pulmonary disease (COPD), and emphysema. Breyna, available in various dosage strengths, signifies a crucial advancement in providing accessible and cost-effective treatment options for individuals facing respiratory challenges.

In March 2023, UC Davis Health, an academic health institution based in the United States, entered into a collaboration with Propeller Health to offer individualized treatment for chronic obstructive pulmonary disease (COPD) and asthma through remote patient monitoring technology. This partnership allows UC Davis Health to provide eligible patients with Propeller Health's remote patient monitoring (RPM) service, delivering personalized therapy for high-risk COPD and asthma patients using sensors, a smartphone application, and a website. Propeller Health, a U.S.-based mobile platform company, provides sensors, mobile apps, analytics, and services to assist in respiratory health management.

Major companies operating in the emphysema treatment market report are AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Bioxyne Limited, Intrexon Corporation, iCure Pharmaceuticals Inc., Kamada Ltd., Emphasys Medical Inc., Halozyme Therapeutics Inc., Mariposa Health Limited, Uptake Technologies Inc., British Technology Group International , Astellas Pharma Inc., Respinova Ltd., Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc., Olympus Corporation

North America was the largest region in the emphysema treatment market in 2023. The regions covered in the emphysema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the emphysema treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The emphysema treatment market includes revenues earned by entities by providing medical services such as bronchodilator medications, anti-inflammatory medication, oxygen therapy, lifestyle change consultation, and interventional therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Emphysema Treatment Market Characteristics

3. Emphysema Treatment Market Trends And Strategies

4. Emphysema Treatment Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Emphysema Treatment Market Size and Growth

• 5.1. Global Emphysema Treatment Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Emphysema Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Emphysema Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Emphysema Treatment Market Segmentation

• 6.1. Global Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Smoking Cessation
• Bronchodilators
• Steroids
• Leukotriene Modifiers
• Supplemental Oxygen
• Antibiotics
• Gene Therapy
• Surgery Transplant
• Other Treatments
• 6.2. Global Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Online Providers
• Drug Stores and Retail Pharmacies
• Hospital Pharmacies
• 6.3. Global Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Clinics
• Surgical Centre
• Other End-Users

7. Emphysema Treatment Market Regional And Country Analysis

• 7.1. Global Emphysema Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Emphysema Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Emphysema Treatment Market

• 8.1. Asia-Pacific Emphysema Treatment Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Emphysema Treatment Market

• 9.1. China Emphysema Treatment Market Overview
• 9.2. China Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Emphysema Treatment Market

• 10.1. India Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Emphysema Treatment Market

• 11.1. Japan Emphysema Treatment Market Overview
• 11.2. Japan Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Emphysema Treatment Market

• 12.1. Australia Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Emphysema Treatment Market

• 13.1. Indonesia Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Emphysema Treatment Market

• 14.1. South Korea Emphysema Treatment Market Overview
• 14.2. South Korea Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Emphysema Treatment Market

• 15.1. Western Europe Emphysema Treatment Market Overview
• 15.2. Western Europe Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Emphysema Treatment Market

• 16.1. UK Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Emphysema Treatment Market

• 17.1. Germany Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Emphysema Treatment Market

• 18.1. France Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Emphysema Treatment Market

• 19.1. Italy Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Emphysema Treatment Market

• 20.1. Spain Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Emphysema Treatment Market

• 21.1. Eastern Europe Emphysema Treatment Market Overview
• 21.2. Eastern Europe Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Emphysema Treatment Market

• 22.1. Russia Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Emphysema Treatment Market

• 23.1. North America Emphysema Treatment Market Overview
• 23.2. North America Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Emphysema Treatment Market

• 24.1. USA Emphysema Treatment Market Overview
• 24.2. USA Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Emphysema Treatment Market

• 25.1. Canada Emphysema Treatment Market Overview
• 25.2. Canada Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Emphysema Treatment Market

• 26.1. South America Emphysema Treatment Market Overview
• 26.2. South America Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Emphysema Treatment Market

• 27.1. Brazil Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Emphysema Treatment Market

• 28.1. Middle East Emphysema Treatment Market Overview
• 28.2. Middle East Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Emphysema Treatment Market

• 29.1. Africa Emphysema Treatment Market Overview
• 29.2. Africa Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Emphysema Treatment Market Competitive Landscape And Company Profiles

• 30.1. Emphysema Treatment Market Competitive Landscape
• 30.2. Emphysema Treatment Market Company Profiles
  • 30.2.1. AstraZeneca PLC
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Teva Pharmaceutical Industries Ltd.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Novartis AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. GlaxoSmithKline PLC
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Hikma Pharmaceuticals PLC
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Emphysema Treatment Market Competitive Benchmarking

32. Global Emphysema Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Emphysema Treatment Market

34. Emphysema Treatment Market Future Outlook and Potential Analysis

• 34.1 Emphysema Treatment Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Emphysema Treatment Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Emphysema Treatment Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer